| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/04/2006 | EP1611892A2 Pharmaceutical compositions comprising drospirenone |
| 01/04/2006 | EP1611887A2 Modulation of peroxisome proliferator-activated receptors |
| 01/04/2006 | EP1611886A2 Inhibitors of the renin-angiotensin system for the prevention of cardiovascular disorders |
| 01/04/2006 | EP1611151A2 Stq-peptides |
| 01/04/2006 | EP1611144A1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists |
| 01/04/2006 | EP1611132A1 Substituted pyrroline kinase inhibitors |
| 01/04/2006 | EP1611130A2 Reverse-turn mimetics and method relating thereto |
| 01/04/2006 | EP1611121A1 Pyridazinone derivatives as cdk2-inhibitors |
| 01/04/2006 | EP1611109A1 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/04/2006 | EP1610811A2 Prevention and treatment of cardiac arrhythmias |
| 01/04/2006 | EP1610810A2 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 01/04/2006 | EP1610798A2 Estradiol metabolites for the treatment of pulmonary hypertension |
| 01/04/2006 | EP1610792A1 Calcium channel blockers comprising two benzhydril moieties |
| 01/04/2006 | EP1610775A2 Combination drug therapy for treating hypertension |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1494658B1 Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases |
| 01/04/2006 | EP1408030B1 Novel aliphatic compound, method of synthesis, and method of utilization |
| 01/04/2006 | EP1351688A4 Urotensin-ii receptor antagonists |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1309557B1 Amlodipine hemimaleate |
| 01/04/2006 | EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 01/04/2006 | EP1265621B1 Use of cdp-choline for the prophylactic treatment of cerebral ischemia |
| 01/04/2006 | EP1173172B1 Synergistic effects of amlodipine and the hydroxylated metabolite of atorvastatin |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1147772B1 Use of 1,4-benzothiazepine derivatives for the preparation of a medicament FOR the TREATMENT OF ATRIAL FIBRILLATION |
| 01/04/2006 | EP1067945B1 Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions |
| 01/04/2006 | EP0934288B1 Oxadiazoles, processes for their preparation and their use as medicaments |
| 01/04/2006 | EP0932399B1 Water soluble paclitaxel prodrugs |
| 01/04/2006 | CN1717415A Peptide gap junction modulators |
| 01/04/2006 | CN1717391A Inhibitors of glycogen synthase kinase 3 |
| 01/04/2006 | CN1717254A Methods for treating or preventing angiogenesis-dependent symptoms |
| 01/04/2006 | CN1717251A Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 01/04/2006 | CN1717232A Use of l-carnitine for the treatment of cardiovascular diseases |
| 01/04/2006 | CN1717228A Pharmaceutical composition comprising a LTB4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 01/04/2006 | CN1715926A Neuregulin mutant, screening method and use |
| 01/04/2006 | CN1715280A Aryl fused azapolycyclic compounds |
| 01/04/2006 | CN1715279A Repinotan analogue,its preparing method and use |
| 01/04/2006 | CN1715277A Compound for treating cardiocerebral vascular disease and its preparing method and its use in pharmaceutical field |
| 01/04/2006 | CN1715275A Simple process for preparing trimetazidine and its medicinal salts |
| 01/04/2006 | CN1715262A Peroxisome propogation agent activating receptor gamma ligand excitomotor and its use |
| 01/04/2006 | CN1714867A Triacetin as a transdermal penetration enhancer |
| 01/04/2006 | CN1714866A A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| 01/04/2006 | CN1714859A Use of composition containing red-rooted salvia root in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714857A Use of medicinal composition containing pilose antler for treating chronic brain blood supply deficiency |
| 01/04/2006 | CN1714851A Use of medicinal composition containing gastrodia elata for treating chronic brain blood supply deficiency |
| 01/04/2006 | CN1714850A Use of medicinal composition containing ligusticum wallichii for treating chronic brain blood supply deficiency |
| 01/04/2006 | CN1714849A Maluoning powder injection for injection and its preparing method |
| 01/04/2006 | CN1714847A Use of medicine containing red-rooted salvia root in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714839A Use of medicinal composition in preparing medicine for treating chronic brain blood supply deficiency |
| 01/04/2006 | CN1714837A Use of medicine containing haw in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714836A Use of medicine in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714833A Use of medicine in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714832A Medicinal composition with synergetic function |
| 01/04/2006 | CN1714831A Use of medicinal composition in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1714830A Use of medicinal preparation in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1714829A Use of medicine containing read-rooted salvia root in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1714828A Use of injection in preparing medicine for breating anti aspirin |
| 01/04/2006 | CN1714827A Use of medicine in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714826A Use of red-rooted salvia root and pseudo-ginseng preparation in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714825A Use of composition in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714824A Use of preparation in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714823A Use of dripping pill in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714822A Use of medicine containing ligusticum vallichii in preparing medicine for treating anti-aspirin |
| 01/04/2006 | CN1714821A Use of medicine containing boxwood in anti-aspirin medicine |
| 01/04/2006 | CN1714820A Use of medicine in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1714819A Medicinal composition for treating coronary heart disease |
| 01/04/2006 | CN1714818A Use of medicinal composition in preparing medicine for treating cardiocytes fading |
| 01/04/2006 | CN1714815A Bee glue and saussurea involucrata wine |
| 01/04/2006 | CN1714814A Use of medicine containing erigeron breviscapus in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1714812A Use of medicine containing pseudo-ginseng and borneol in preparing medicine for treating anti aspirin |
| 01/04/2006 | CN1714804A Blood circulation invigorating and channels obstruction removing thin film coated tablet using leech powder as only active component |
| 01/04/2006 | CN1714798A Medicinal coposition for treating cardiocerebral vascular diseases |
| 01/04/2006 | CN1714797A Medicinal use of paeoniflorin |
| 01/04/2006 | CN1714796A Medicine for treating cardiocerebral vascular diseases |
| 01/04/2006 | CN1714794A Irbesartan hydrochlorothiazine dispersible tablet an dits preparing method |
| 01/04/2006 | CN1714789A Candesartan hydrochlorothiazine dispersible tablet and its preparing method |
| 01/04/2006 | CN1234717C N, O-carboxymethyl chitoligose, its preparation and use |
| 01/04/2006 | CN1234712C 2-zminoalkyl-thieno [2, 3-D] pyrimidines |
| 01/04/2006 | CN1234711C Mikanolide derivatives,their preparation and its therapeutic uses |
| 01/04/2006 | CN1234708C Novel imidazotriazinones and the use thereof |
| 01/04/2006 | CN1234702C Benzopyran compound, and pharmaceutical composition including them |
| 01/04/2006 | CN1234698C Nitric oxide donors based on metallic centers |
| 01/04/2006 | CN1234694C New imidazoline compound, its preparation method and drug composition containing them |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234414C Drugs for complications of diabetes and neuropathy and utilization thereof |
| 01/04/2006 | CN1234410C Brain protein hydrolysate freeze-drying powder injection and its preparing method |
| 01/04/2006 | CN1234399C Method for preparing mailuoning freeze-dried powder for injection |
| 01/04/2006 | CN1234398C Oral medicine for treating arteriosclerosis and its manufacturing method |
| 01/04/2006 | CN1234393C Chinese patent drug for treating essential hypotention |
| 01/04/2006 | CN1234370C Chinese medicine injection for treating cardio-cerebral vascular diseases and shock first-aid |
| 01/04/2006 | CN1234359C Use of oxidized matrine in preparation of chemicals for treating viral myocarditis |
| 01/04/2006 | CN1234357C Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/04/2006 | CN1234351C Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use |
| 01/04/2006 | CN1234299C Nutrient flour special for diabetes and hypertension patients |
| 01/03/2006 | US6982362 for diagnosis/treatment of arteriosclerosis, diabetes; stem cells |
| 01/03/2006 | US6982350 reduction of 4,5-dimethoxy-1-cyano-benzocyclobutane, resolution with optically active diacid (N-acetyl-L-glutamic acid), amidification and reduction; improved yield and optical purity; chemical intermediates; antiischemic agents |
| 01/03/2006 | US6982286 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO), treat an inflammatory disease or condition, a disease related to carbohydrate metabolism, smooth muscle cell function |
| 01/03/2006 | US6982279 Arylated furan- and thiophenecarboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 01/03/2006 | US6982278 For modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus |